NCT05400798 - A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears | Biotech Hunter

Enrollment

246

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions

Partial Thickness Rotator Cuff Tear

Interventions

DEVICE

Adipose Derived Regenerative Cells

single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rotator cuff tear

DEVICE

Corticosteroid

a single corticosteroid injection into the associated subacromial space

Trial Locations (11)

Georgia Institute for Clinical Research, Marietta

Andrews Institute for Orthopedics and Sports Medicine, Gulf Breeze

Sports and Orthopedic Center, Coral Springs

Universal Axon Clinical Research, Doral

Sanford Orthopedic Clinic/Research, Sioux Falls

Tulane University School of Medicine, New Orleans

HD Research, Houston

Texas Center for Cell Therapy and Research, San Antonio

Arizona Research Center, Phoenix

Lotus Clinical Research, LLC, Pasadena

Biosolutions Clinical Research Center, La Mesa